Loading...
Market
Story
British Volunteers to Trial World's First Norovirus Vaccine Against Winter Vomiting Bug
Oct 22, 2024, 11:14 PM
British researchers are set to trial the world's first vaccine against the vomiting bug norovirus. The vaccine, which will be tested on thousands of British volunteers, aims to combat the winter vomiting bug. The trial seeks to provide a preventive measure against norovirus, a common and highly contagious virus that causes gastroenteritis, according to BBCDorset.
View original story
Similar markets
Very Positive • 25%
Somewhat Positive • 25%
Neutral • 25%
Negative • 25%
Very Positive • 25%
Somewhat Positive • 25%
Neutral • 25%
Negative • 25%
Increased Confidence • 25%
Decreased Confidence • 25%
No Change • 25%
Other • 25%
Majority positive • 25%
Majority negative • 25%
Evenly split • 25%
Insufficient data • 25%
High (>70%) • 25%
Moderate (50-70%) • 25%
Low (30-50%) • 25%
Very Low (<30%) • 25%
Increased trust • 25%
Decreased trust • 25%
No significant change • 25%
Mixed responses • 25%
Increase in support • 25%
Decrease in support • 25%
No change • 25%
Mixed opinions • 25%
Widespread support • 25%
Mixed reactions • 25%
Predominantly negative • 25%
Major public protests • 25%
Mostly positive • 25%
Mostly negative • 25%
Mixed • 25%
Indifferent • 25%
More positive • 33%
More negative • 33%
No significant change • 33%
Majority support changes • 25%
Majority oppose changes • 25%
Public opinion divided • 25%
Insufficient data • 25%
Mostly positive • 25%
Mostly negative • 25%
Mixed • 25%
Indifferent • 25%